The Omicron variant is by far the most dominant of the COVID virus strains in our region at this time. Dr. John Zurlo, Chief of Infectious Diseases updates us on what we’re seeing in the hospitals, new monoclonal antibody therapies Sotrovimab and Evusheld, and the accuracy of at-home tests. Plus, he addresses whether the United States will follow in the footsteps of Germany and Israel and expedite an additional booster.

For more on the latest with COVID, read about Boosters, Floosters, and the Omicron Variant.